Ftse Mib
34.249,77
0,91%
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
NASDAQ Composite
15.927,90
2,03%
Bitcoin
63.492,24
0,13%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni U.S.A. NASDAQ Oncternal Therapeutics Inc (ONCT) Oncternal Therapeutics Inc (ONCT) Notizie

Oncternal Therapeutics Inc

ONCT
8,29
0,04 (0,48%)
27 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
08/3/202422:42EDGAR2Form S-3 - Registration statement under Securities Act of..
07/3/202422:20EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/3/202422:10EDGAR2Form 8-K - Current report
27/2/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202422:05EDGAR2Form 8-K - Current report
05/1/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202422:00EDGAR2Form 8-K - Current report
09/11/202322:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:15EDGAR2Form 8-K - Current report
06/10/202322:31EDGAR2Form 8-K - Current report
04/10/202323:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202323:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202322:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202322:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202322:01EDGAR2Form 8-K/A - Current report: [Amend]
10/8/202322:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202322:11EDGAR2Form 8-K - Current report
06/7/202300:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/7/202300:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/7/202300:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/7/202300:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/6/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/6/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/6/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/6/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/6/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/6/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/6/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/6/202312:01EDGAR2Form 8-K - Current report
Apertura: 8,32 Min: 8,00 Max: 8,32
Chiusura: 8,25

La tua Cronologia

NASDAQ
ONCT
Oncternal Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network